Companies/US/TRAW

TRAWS PHARMA, INC.

Income flow

Annual
TRAW 10-K Income StatementPeriod 2025-12-31Source 10-K
Single Reportable SegmentUNIT_STA 3MRevenueUNIT_STA 3M+1135% Y/YNet profitUNIT_STA 7MTaxUNIT_STA 2M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · UNIT_STA
By activity
By activityUNIT_STA 3M
  • Single Reportable SegmentUNIT_STA 3M100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).15.4MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).11.9M
Stock splits
  1. 1:252024-09-23
  2. 1:152021-05-21
  3. 1:152018-09-26

Valuation

Trailing PE 1.4 (2025-12-31)PE trend

Fiscal PE1

PeriodEPSClosePE
2025-12-310.821.131.4

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.